The ATM-dependent accumulation of p53 and induction of p21 waf1 are key events for G1 cell-cycle checkpoint arrest following DNA damage. In ATM-null AT cells, even though the p53 and p21 waf1 responses are kinetically delayed and quantitatively reduced, the G1 checkpoint is virtually disrupted, suggesting that these proteins arrive too late in G1 to enforce the arrest. As the precise mechanism remains unclear, we examined the response to DNA double-strand breaks generated by c-radiation (IR), to determine if ATM deficiency affects the cell-cycle phase regulation of these molecules. We find that, after irradiation, whereas normal LCL-N cells markedly increase their levels of p53 in all phases of the cell cycle, AT cells fail to show any p53 increase in the G1 phase. In addition, whereas in LCL-N p21 waf1 is induced in G1 and G2-M, in AT cells this induction is partly seen in G2-M, but not in G1, indicating a different cell-cycle phase regulation of p53 and p21 waf1 as a result of ATM deficiency. The levels and catalytic activity of the p53-targeting kinases ATR and DNA-PK in LCL-N and AT cells are very similar throughout the cell cycle, both before and after IR, thus excluding a phase-specific activity for these kinases. Collectively, our findings demonstrate that, in ATM-deficient cells, the p53-dependent p21 waf1 response to DNA damage is not only quantitatively reduced, but also specifically suppressed in the G1 phase, thus providing a mechanistic explanation for the severe disruption of the G1 checkpoint in AT cells.
Introduction
The cellular response to DNA damage involves the activation of checkpoint pathways that impose the delay of cell-cycle progression and control DNA repair and replication (Khanna and Jackson, 2001) . Key molecules for the initiation of the damage response are ATM (Ataxia Telangiectasia Mutated) and ATR (ATM and Rad3 related), members of a family of nuclear kinases essential for transducing genomic stress signals and activating multiple cell-cycle checkpoints (Abraham, 2001; Shiloh and Kastan, 2001) . Following DNA damage, ATM undergoes rapid autophosphorylation and dimer dissociation, leading to its activation (Bakkenist and Kastan, 2003) . Among other targets, activated ATM phosphorylates p53 on serine 15 (Banin et al., 1998; Khanna et al., 1998) and indirectly, via Chk2, on serine 20 (Chehab et al., 2000) . Both events contribute to p53 nuclear accumulation and transcriptional induction of p21 waf1 , an inhibitor of the cyclindependent kinase 2/cyclin E complex required for cell-cycle progression from G1 to S phase El-Deiry et al., 1994; Bartek and Lukas, 2001) .
Like ATM, ATR participates in checkpoint responses to genotoxic agents (Abraham, 2001; Shiloh, 2003) , but the function of these kinases is only partly overlapping. For instance, ATM responds to DSBs only, whereas ATR, in addition, responds to UV damage and replication arrest. ATR, too, phosphorylates p53 on Ser15 (Lakin et al., 1999; Tibbetts et al., 1999) , but this event is thought to sustain the activation of p53 triggered by ATM. Unlike ATM, ATR is essential for cell proliferation and mouse embryo viability (de Klein et al., 2000) .
Cells lacking ATM, such as those from Ataxia Telangiectasia (AT) patients, fail to elicit a p53/p21 waf1 response and to impose a G1 checkpoint arrest following DNA damage (Khanna et al., 1995; Beamish et al., 1996; Delia et al., 2000) . Curiously, although the accumulation of p53 and induction of p21 waf1 in AT cells are delayed and quantitatively reduced (Takagi et al., 1998) , the G1 checkpoint is entirely disrupted, hence suggesting that either the transcriptional function of p53 is exerted when expressed above a certain threshold level, or that in the absence of ATM, the other members of the PI3K family of molecules known to target p53, for example, ATR and DNA-PK (Durocher and , are somehow unable to activate p53 at the G1 phase. To elucidate this issue, we analysed the p53-dependent response to IR in normal and AT cells fractionated by FACS according to the cell-cycle phase. In LBC-N cells at 3 h post-IR, the amount of total p53 and p53 phosphorylated on Ser15 (p53-P-Ser15) increased in all phases of the cell cycle ( Figure 1a) . Moreover, induced levels of p21 waf1 were seen in G1 and G2/M, but not in S-phase cells. Conversely, in irradiated AT cells, the levels of p53 and p53-P-Ser15 were reduced by B60% (Figure 1a) , but, surprisingly, differently expressed along the cell cycle, with G1-phase cells being negative (Figure 1b) . Likewise, the induction of p21 waf1 could be demonstrated in G2/M but not G1, though at reduced levels than normal cells (Figure 1a-c) .
The limited induction of p21 waf1 in AT cells was dependent on p53, according to two distinct observations. First, in LFS cells carrying inactive p53, no induction of p21 waf1 could be seen in any phase of the cell cycle (Figures 2 and 1c) , even though the ATM/ATRdependent DNA damage response pathway was functional, as evidenced by the normal phosphorylation of p53-Ser15 ( Figure 2 ). Second, both the accumulation of p53 and p53-P-Ser15 and the induction of p21 waf1 in AT cells could be suppressed by pretreatment with 2 mM caffeine ( Figure 3 ), an inhibitor of ATM and ATR . It is noted that caffeine did not completely abolish p53 induction in LBC-N, suggesting a different sensitivity by these cells to the inhibitor.
The findings above indicate that, in the absence of ATM, other members of the PI-3 kinase family, for example, ATR or DNA-PK, could regulate p53, but somewhat differently from ATM. ATR can phosphorylate p53 serine 15 in vitro and in vivo , but the role of this kinase in DNA double-strand break responses in normal cells appears secondary to that of ATM (Abraham, 2001; Shiloh and Kastan, 2001) . DNA-PK can also phosphorylate p53 Ser15 in vitro (Kim et al., 1999) , but the contribution of this kinase in vivo remains controversial (Jhappan et al., 2000; Woo et al., 2002) . We thus determined whether the expression and catalytic activity of ATR and DNA-PK differed among the cell-cycle phases of AT cells.
LBC-N and AT cells expressed similar amounts of ATR protein, even after irradiation, and this was also true for DNA-PK (data not shown). Likewise, no significant differences in the levels of these molecules were found among G1, S and G2-M, both in LBC-N and AT (Figure 4a ), thus ruling out a cell-cycle phaserestricted expression for these kinases. To measure the in vitro kinase activity, ATR and DNA-PK were immunoprecipitated from G1-, S-and G2-M-phase cells fractionated before or 1 h after irradiation, and assayed waf1 throughout the cell-cycle phases in normal, AT and LFS cells at 3 h after IR, as determined by densitometric analysis of at least three separate experiments. The EBVimmortalized lymphoblastoid cells used in this study were derived from a normal individual (LBC-N), from patients with AT (AT21RM and AT52RM bearing ATM mutations IVS18 þ 1delG and 7327C-T/ 8365delA, respectively) (Delia et al., 2000) or Li-Fraumeni syndrome (LFS) . Cells were cultured as described (Delia et al., 2000) , and irradiated on a IBL437CO instrument (Oris Industries, France) equipped with a 137 Cesium source emitting 798 cGy/min. Separations according to the cell-cycle phase were performed on a FACS-Vantage equipped with a UV laser and a refrigeration system, on samples labelled for 20 min prior to sorting with 10 mg/ml of Hoechst 33342 (Calbiochem, La Jolla, CA, USA). Cell pellets were lysed in Laemmli buffer (0.125 M Tris-HCl, pH 6.8, 5% SDS) containing 1 mM PMSF, 10 mg/ml pepstatin, 100 KIU/ml aprotinin, 10 mg/ml leupeptin (all from Calbiochem) and 1 mM sodium orthovanadate (Sigma) as inhibitors. Aliquots containing 40 mg/ml of protein plus 5% mercaptoethanol were size-fractionated on 12% or 7% SDS-PAGE, and electroblotted onto PVDF membranes (Millipore, Bedford, MA, USA). ATM, ATR and DNA-PK were fractionated on a two-gradient SDS-PAGE (Delia et al., 2000) . Binding of primary antibodies to the membranes was revealed by ECL super signal (Pierce). The monoclonal antibodies to human p53 (clone DO7) and p21
Waf1 were from Dako and Neomarkers, respectively. The rabbit antibody to phosphorylated p53-Ser15 (Shieh et al., 1997) was a kind gift of Dr Yoichi Taya, National Cancer Research Center, Tokyo. Membranes were reprobed with rabbit antibodies to b-actin (Sigma). ECL signals on autoradiographs were optically scanned and quantitated using ImageQuant software (Molecular Dynamics). For each lane, the p21
waf1 densitometric values were corrected for b-actin, and normalized in AT and LFS against those of LBC-N p53 and p21 waf1 responses in AT cells D Delia et al against p53 and PHAS1 substrates. Under these conditions, the basal enzymatic activity of ATR and DNA-PK (the latter about 15-fold greater than that of ATR) was similar in all phases of the cell cycle, and did not change after IR in both normal (not shown) and AT cells (Figure 4b ). These results would exclude the possibility that the lack of radiation-induced p53 response in G1 arises from a decreased expression and/or activity of ATR or DNA-PK in this specific phase of the cell cycle.
Altogether, we have demonstrated that the basal levels of p53 protein in LCL-N cells are greatly enhanced in all phases of the cell cycle after 10 Gy of IR, whereas, in AT cells, these induced levels of p53, overall reduced compared to LCN-N cells, are specifically deficient in the G1 phase. Likewise, the radiationinduced p21 waf1 protein that in LCL-N is detectable in G1 and G2-M, in AT cells is detectable in G2-M, but not in G1-phase cells. From these results, we can conclude that in cells lacking ATM function, the radiation-induced expression of p53, and consequently of p21 waf1 , albeit reduced, appears cell-cycle phase dependent. In vitro kinase assays have also shown that the catalytic activity of ATR and DNA-PK is similar among G1, S and G2-M phases, both before and after IR. Incidentally, our failure to detect any changes in ATR activity after IR or cell-cycle-related differences in DNA-PK activity is in agreement with previous reports (Abraham, 2001; Yoshida et al., 2002) .
Collectively, our findings demonstrate that, in ATMdeficient cells, the p53-dependent p21 waf1 response to DNA damage is not only quantitatively reduced, but also specifically absent in the G1 phase, thus providing a mechanistic explanation for the severely disrupted G1 checkpoint in AT cells.
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Figure 2 p53 and p21 waf1 radiation responses in p53-deficient LFS cells. Western blot analysis performed on cells fractionated before or 3 h after 10 Gy of IR. The LFS cell line carries a heterozygous inactivating mutation of p53 at codon 286 . Note the similar accumulation of p53 and p53-P-Ser15 in LFS and LBC-N cells in both G1 and G2/M phases, and the lack of IR-induced p21 waf1 in LFS cells
p53-P-Ser15 β-act Cell-cycle phase expression and catalytic activity of ATR and DNA-PK. Lysates from sorted cells were analysed by Western blot (a) or subjected to in vitro kinase assays against p53 and Phas1 substrates (b). Cell lysates and kinase assays were performed as reported (Sarkaria et al., 1998 . Briefly, cells were lysed in LB buffer (20 mM HEPES pH 7.4, 150 mM NaCl, 1 mM EGTA, 1 mM DTT, 10 mg/ml aprotinin, 5 mg/ml pepstatin, 10 mM NaF, 20 mM bglycerophosphate, 0.5% NP40). After preclearing, lysates (1 mg) were incubated for 4 h with 4 mg of antibodies to ATR (PA1-450 from ABR, Golden, CO, USA) or DNA-PK (66141A, Pharmingen, San Diego, CA, USA), together with Sepharose-ProtA/G (Sigma), washed 4 Â in LB, twice in LB plus 500 mM LiCl, and once in kinase buffer (KB) (10 mM HEPES pH 7.4, 50 mM NaCl, 10 mM MgCl 2 , 10 mM MnCl 2 , 1 mM DTT). Kinase reactions containing 40 ml KB, 10 mCi g-ATP[
32 P] (50 Ci/mmol), 25 ng/ml recombinant PHAS1 (Calbiochem) or GST-p53 fusion substrate spanning the region across Ser15 were incubated at 301C for 20 min. DNA-PK reactions included 500 ng of sonicated salmon sperm DNA. Reactions were resolved on SDS-PAGE, autoradiographed, electroblotted and tested by ECL for ATR or DNA-PK to verify the amount of immunoprecipitated protein p53 and p21 waf1 responses in AT cells D Delia et al
